Betsy Gelfand is the Vice President of Finance at Mirati Therapeutics, Inc. in San Diego, California. She has over 12 years of experience in the biotechnology industry, primarily with public companies.

Prior to Mirati, Betsy was the Senior Director, Finance at Tocagen, Inc. and helped in the execution of the merger into Forte Biosciences. Earlier in her career, she was the Controller of Regulus Therapeutics, Inc. where she helped build the Accounting and Finance function through the Company’s growth.

Prior to industry, Betsy spent nine years in public accounting, serving biotechnology clients. She received a B.S. in accounting from University of San Diego